Plain-English translation of NCT05661383 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether combining two treatments — a non-invasive brain stimulation called intermittent theta-burst stimulation (iTBS) plus daily exposure to pleasant odors — works better than brain stimulation alone for people with depression that hasn't responded to antidepressant medications. The brain stimulation targets an area involved in mood and reward, while the pleasant scents are meant to activate the same reward system in a complementary way.
Depression that doesn't improve with standard antidepressant medications affects many people and leaves them with limited options. This study explores whether pairing brain stimulation with a simple, enjoyable intervention like scent exposure might enhance the treatment's effectiveness, particularly for the loss of pleasure that is a hallmark of depression.
You likely qualify if…
You likely don't qualify if…
You would receive brain stimulation sessions (iTBS) targeting a specific brain region involved in mood and reward. Half of participants would receive the stimulation alone, while the other half would receive it while simultaneously being exposed to pleasant scents. The study involves multiple visits over several weeks to deliver treatment and track your progress using standard depression rating scales and brain imaging to understand how the treatment affects your brain activity.
AI-generated summary from trial data · Jul 11, 2026 · Not medical advice
France